https://www.selleckchem.com/products/lb-100.html
Ventricular tachycardia (VT) is a life-threatening condition, which usually implies the need of an implantable cardioverter defibrillator in combination with antiarrhythmic drugs and catheter ablation. Stereotactic body radiotherapy (SBRT) represents a common form of therapy in oncology, which has emerged as a well-tolerated and promising alternative option for the treatment of refractory VT in patients with structural heart disease. In the STRA-MI-VT trial, we will investigate as primary endpoints safety and efficacy of SBRT for the tre